Treatable Diagnoses

Hyperbaric Oxygen Therapy (HBOT) is the definitive treatment for decompression sickness (DCS) and air or gas embolisms, conditions often seen in divers and individuals exposed to rapid changes in pressure. 

Hyperbaric Oxygen Therapy (HBOT) is emerging as a potential adjunctive treatment for Rheumatoid Arthritis (RA), leveraging its anti-inflammatory and tissue regenerative properties.

Over the past 26 years, we have provided treatment to numerous children diagnosed with Autism Spectrum Disorder (ASD).

Hyperbaric oxygen therapy (HBOT) has been shown to increase telomere length and clear senescent (or defunct) cells in aging populations, both of which effectively reverse age-related decline. HBOT has been shown to help patients think faster and feel greater vitality and less pain.

Studies of HBOT for AVN show a decrease in pain, increased movement, and the prevention of joint collapse with early intervention.

Acute ischemia occurs when blood flow is suddenly reduced or blocked, depriving tissues of oxygen and nutrients, which can cause serious damage. Hyperbaric oxygen therapy (HBOT) boosts oxygen levels in the blood, helping to reduce tissue damage, promote healing, and improve recovery.

The FDA, AMA and Medicare support the use of Hyperbaric Oxygen Therapy (HBOT) to help heal chronic refractory osteomyelitis, and numerous private insurance companies also cover the condition. Our physician partners refer patients to HBOT as an adjunct to antibiotics and surgery.

HBOT halts ongoing radiation damage to breast tissues and is used as an adjunct to skin grafting for necrosis of the chest wall after mastectomy. 

Hyperbaric oxygen therapy has ben shown to remove carboxyhemoglobin faster than any other treatment, including oxygen alone.

It is critical that patients receive hyperbaric oxygen within 24 hours of an injury causing CRAO in order to reverse it completely.

Studies show that between a 78% and 88% of Crohn’s patients who receive hyperbaric oxygen therapy experience significant improvement.

We have seen numerous cases of chronic pain from dozens of underlying conditions resolved.

Hyperbaric oxygen therapy re-oxygenates ischemic tissues, decreases this pressure, and speeds healing of tissues that were damaged.

Numerous studies conducted over the last twenty years show that hyperbaric oxygen therapy (HBOT) supports the healing of failing or compromised grafts and flaps, even those with underlying complications, such as radiation injuries, tissue or bone infection and diabetes.

Physicians increasingly refer HBOT for patients with TBI and anoxic brain injury, because studies with brain imaging show angiogenesis and neuroplasticity.

HBOT is approved by Medicare and reimbursed by a number of private insurance companies for crush injuries.

HBOT helps the brain regenerate, most frequently reducing symptoms of dementia.

Hyperbarics is the primary medical treatment for resolving decompression sickness caused by air and gas embolisms in the body. Oxygen under pressure dissolves bubbles in the bloodstream, allowing them to be safely reabsorbed by the body.

Depression caused by brain injury can be healed with hyperbaric oxygen therapy.

Erectile dysfunction (ED) become one of the most common and challenging conditions that Urologists contend with in working with male patients today. ED can be a marker for cardiovascular disease, given that it is most frequently caused by microvascular or macrovascular insufficiency. Treatments today typically range from medication to surgery.

Many FMS patients show brain scan lesions. Studies show that HBOT heals these lesions, leading to dramatic increases in brain function.

Patients with FASD show an improvement in verbal memory, impulse control and reaction time composites from HBOT.

Numerous studies conducted over the last twenty years show that hyperbaric oxygen therapy (HBOT) supports the healing of failing or compromised grafts and flaps, even those with underlying complications, such as radiation injuries, tissue or bone infection and diabetes.

Many providers refer patients to HBOT to reduce the incidence and severity of headaches. Migranes at times resolve in just one treatment.

In recent studies, 78% of patients with Crohn's disease improved with HBOT, and 100% with ulcerative colitis were healed.

HBOT kills the spirochetes believed to cause Lyme disease. It also kills bacteria and heals damage done by bacteria.

HBOT often resolves migraines in one treatment, whereas patients with intervening neurological problems can require additional intervention.

Healthcare providers recommend patients to Hyperbarics to heal non-healing wounds more than any other medical condition.

HBOT increases the cure rate for refractory osteomyelitis to 86% when used as an adjunct to other treatments such as antibiotics.

HBOT increases neovascularization by angiogenesis and vasculogenesis, is bactericidal, and improves post-ischemic tissue survival.

Medicare, the AMA and the FDA support HBOT as a proven treatment for Hemorrhagic Cystitis and 76% of patients show significant resolution of their HRC after HBOT.

HBOT halts ongoing radiation damage to breast tissues. It stimulates angiogenesis in hypoxic tissue, correcting ischemias after mastectomies.

The FDA and Medicare approve the use of hyperbaric oxygen therapy to treat osteoradionecrosis, and the evidence shows that HBOT helps heal an overwhelming percentage of patients who have osteoradionecrosis.

Hyperbaric oxygen therapy (HBOT) has shown to be beneficial in the standard of care in treating radiation proctitis. It also helps heal radiation cystitis and radionecrosis.

Hyperbaric oxygen therapy (HBOT) increases blood flow and transports more oxygen through the plasma to the inner ear and nerve cells, thus reducing hypoxia. HBOT has been shown to reduce inflammation and promote stem cell growth and mobilization.

Professional athletes and the fitness minded are turning to Hyperbaric Oxygen Therapy to help improve their sports performance and to achieve a rapid recovery from surgeries and injuries.

55% of stroke participants experience significant improvement after HBOT, while 72% have at least a mild improvement

In 6 studies on the use of HBOT on ulcerative colitis, 100% of patients showed improvement.